SAN DIEGO, Oct. 30, 2025 /PRNewswire/ — ChemDiv, a global provider of integrated drug discovery solutions, today announced the extension of its Chemistry, Manufacturing and Controls (CMC) services collaboration supporting the clinical development of ratutrelvir, a promising oral…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
